Cited by 224Neuroinflammation and Neurodegeneration MechanismsImmune Response and InflammationChemokine receptors and signaling

Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge

Open access
Wynne, Angela M., Henry, Christopher J., Huang, Yan, Cleland, Anthony, Godbout, Jonathan P.·2010·Brain, Behavior, and Immunity

Abstract

Fractalkine (CX(3)CL1) to fractalkine receptor (CX(3)CR1) interactions in the brain are involved in the modulation of microglial activation. Our recent findings indicate that there is microglial hyperactivity in the aged brain during an inflammatory challenge. The underlying cause of this amplified microglial response in the aged brain is unknown. Therefore, the purpose of this study was to determine the degree to which age-associated impairments of CX(3)CL1 and CX(3)CR1 in the brain contribute to exaggerated microglial activation after intraperitoneal (i.p.) injection of lipopolysaccharide (LPS). Here we show that CX(3)CL1 protein was reduced in the brain of aged (18-22 mo) BALB/c mice compared to adult (3-6 mo) controls. CX(3)CL1 protein, however, was unaltered by LPS injection. Next, CX(3)CR1 levels were determined in microglia (CD11b(+)/CD45(low)) isolated by Percoll density gradient separation at 4 and 24h after LPS injection. Flow cytometric and mRNA analyses of these microglia showed that LPS injection caused a marked decrease of CX(3)CR1 and a simultaneous increase of IL-1β at 4h after LPS injection. While surface expression of CX(3)CR1 was enhanced on microglia of adult mice by 24h, it was still significantly downregulated on a subset of microglia from aged mice. This protracted reduction of CX(3)CR1 corresponded with a delayed recovery from sickness behavior, prolonged IL-1β induction, and decreased TGFß expression in the aged brain. In the last set of studies BV2 microglia were used to determine effect of TGFß on CX(3)CR1. These results showed that TGFβ enhanced CX(3)CR1 expression and attenuated the LPS-induced increase in IL-1β expression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbi.2010.05.011

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Aged glial cells respond less efficiently to antigens, including amyloid-β and α-synuclein, and have reduced phagocytic and antiinflammatory capacity.

    “Aged glial cells respond less efficiently to antigens, including amyloid-β (Aβ) and α-synuclein, and have reduced phagocytic and antiinflammatory capacity (161–163).”

    From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [163]

  • Cx3cr1 is only expressed by homeostatic microglia and is downregulated by DAM.

    “For example, if a microglial gene relevant to neurodegeneration at an early stage is to be investigated, it would be most appropriate to use a conditional and cell-specific model, such as the tamoxifen-inducible Cx3cr1 Cre recombinase mouse, since Cx3cr1 is only expressed by homeostatic microglia and is downregulated by DAM [66].”
  • In vitro treatment of microglial cells with LPS followed by TGFβ significantly attenuated LPS-induced IL-1β expression.

    “Furthermore, in vitro treatment of microglial cells with LPS followed by TGFβ significantly attenuated LPS-induced IL-1β expression (Wynne et al, 2010).”

    From Microglia Priming with Aging and Stress (2017) · cites this paper as Wynne et al, 2010

  • Aged mice, but not adults, showed reduced baseline levels of CX3CL1 that remained unaltered after a systemic LPS challenge.

    “Aged mice, but not adults, showed reduced baseline levels of CX 3 CL 1 that remained unaltered after a systemic LPS challenge (Wynne et al, 2010).”

    From Microglia Priming with Aging and Stress (2017) · cites this paper as Wynne et al, 2010

  • LPS-injected aged mice showed protracted downregulation of CX3CR1 and reduced social behavior, which was accompanied by elevated IL-1β and reduced TGFβ.

    “LPS-injected aged mice, however, showed protracted downregulation of CX 3 CR 1 and reduced social behavior, which was accompanied by elevated IL-1β and reduced TGFβ (Wynne et al, 2010).”

    From Microglia Priming with Aging and Stress (2017) · cites this paper as Wynne et al, 2010

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 50 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Wynne, A. M., Henry, C. J., Huang, Y., Cleland, A., & Godbout, J. P.
Affiliations
The Ohio State University (US)
Corresponding author
Godbout, Jonathan P.
Venue
Brain, Behavior, and Immunity
Publisher
Elsevier BV
Published
2010-10
Volume
24
Issue
7
Pages
1190-1201
ISSN
0889-1591 (ISSN-L)
OpenAlex
W2087771052
Cited by
224
References
50
Citations by year
2026: 5 · 2025: 5 · 2024: 8 · 2023: 9 · 2022: 17 · 2021: 19 · 2020: 14 · 2019: 13 · 2018: 18 · 2017: 10 · 2016: 18 · 2015: 17 · 2014: 21 · 2013: 18 · 2012: 15
FWCI
9.68
Type
journal article
Language
en
Open access
Locations
  • Brain Behavior and Immunity (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute on Aging (R01AG033028, R01 AG-033028-01)
  • National Institute of Mental Health (R21MH077817)
  • National Institute of Allergy and Infectious Diseases (NIH T32-AI-055411, T32AI055411)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
Keywords
CX3CR1, fractalkine, microglia, aging, lipopolysaccharide, neuroinflammation, microglial activation, IL-1β, TGF-beta, sickness behavior, BV-2 cells, aged mice
MeSH terms
CX3C Chemokine Receptor 1, Aging, Animals, Brain, Cell Count, Cells, Cultured, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Injections, Intraperitoneal, Lipopolysaccharides, Male, Mice, Inbred BALB C, RNA, Messenger, Down-Regulation, Up-Regulation, Polymerase Chain Reaction, Transforming Growth Factor beta, Leukocyte Common Antigens, Microglia, Receptors, Chemokine, CD11b Antigen, Mice, Interleukin-1beta, Chemokine CX3CL1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review